MeiraGTx Holdings (MGTX) Enterprise Value (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Enterprise Value of -$65.9 million for Q4 2025, down 344.25% on a QoQ basis from -$14.8 million in Q3 2025, and up 36.4% year-over-year from -$48.3 million in Q4 2024.
MeiraGTx Holdings (MGTX) Enterprise Value (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Enterprise Value history runs 9 years deep, the most recent figure standing at -$65.9 million for Q4 2025.
- Quarterly Enterprise Value rose 36.4% year-over-year to -$65.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$65.9 million (up 36.4% YoY) and the FY2025 annual result came in at -$65.9 million, up 36.4% from the prior year.
- Enterprise Value was -$65.9 million for Q4 2025 at MeiraGTx Holdings, down from -$14.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$14.8 million in Q3 2025 and bottomed at -$199.4 million in Q1 2021.
- A 5-year average of -$102.8 million and a median of -$108.7 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value plunged 94.14% — and 2025, when it soared 88.13%.
- MeiraGTx Holdings' Enterprise Value stood at -$137.7 million in 2021, then increased by 16.11% to -$115.5 million in 2022, then fell by 13.1% to -$130.6 million in 2023, then increased by 20.66% to -$103.7 million in 2024, then soared by 36.4% to -$65.9 million in 2025.
- Business Quant data shows MGTX's Enterprise Value at -$65.9 million in Q4 2025, -$14.8 million in Q3 2025, and -$32.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | -65.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -65.93 Mn |
| Sep 30, 2025 | -14.84 Mn |
| Jun 30, 2025 | -32.17 Mn |
| Mar 31, 2025 | -66.52 Mn |
| Dec 31, 2024 | -103.66 Mn |
| Sep 30, 2024 | -125.03 Mn |
| Jun 30, 2024 | -101.03 Mn |
| Mar 31, 2024 | -120.27 Mn |
| Dec 31, 2023 | -130.65 Mn |
| Sep 30, 2023 | -64.40 Mn |
| Jun 30, 2023 | -92.77 Mn |
| Mar 31, 2023 | -68.78 Mn |
| Dec 31, 2022 | -115.52 Mn |
| Sep 30, 2022 | -114.71 Mn |
| Jun 30, 2022 | -72.10 Mn |
| Mar 31, 2022 | -113.78 Mn |
| Dec 31, 2021 | -137.70 Mn |
| Sep 30, 2021 | -143.63 Mn |
| Jun 30, 2021 | -172.56 Mn |
| Mar 31, 2021 | -199.41 Mn |